Evidence map›Paper›PMID 24113748›Full record

ArticleMolecular pharmacology2014

FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C(ε)-dependent signaling by its direct interaction with the receptor.

Yu Qiu, Wei Zhao, Yan Wang, Jian-Rong Xu, Eddie Huie, Shan Jiang, Ying-Hui Yan, Horace H Loh, Hong-Zhuan Chen, Ping-Yee Law

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Opioid receptors signaling network.Journal of cell communication and signaling · 2022
    Article
  2. Article
  3. FKBP12 contributes to α-synuclein toxicity by regulating the calcineurin-dependent phosphoproteome.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Yu QiuDepartment of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China (Y.Q., Y.W., J.-R.X., S.J., Y.-H.Y., H.-Z.C.); and Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota (Y.Q., W.Z., E.H., H.H.L., P.-Y.L.).
Wei Zhao
Yan Wang
Jian-Rong Xu
Eddie Huie
Shan Jiang
Ying-Hui Yan
Horace H Loh
Hong-Zhuan Chen
Ping-Yee Law
University of Minnesota · USShanghai Jiao Tong University · CN

Funding

Subcellular Targeting/Packaging of Opioids/ReceptorsP50DA011806 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI WICKMAN, KEVIN D · 1998 to 2012
$14.0M
G-PROTEINS AND OPIOID RECEPTOR FUNCTIONSR01DA007339 · NIDA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI LAW, PING-YEE · 1991 to 2008
$2.5M
Neurochemical Basis of Opiate AddictionR56DA000564 · NIDA · UNIVERSITY OF MINNESOTA · PI LAW, PING-YEE, LOH, HORACE · 2012 to 2013
$329k
NIDA NIH HHS P05DA011806-15A1NIDA NIH HHS P50 DA011806NIDA NIH HHS R01 DA007339NIDA NIH HHS R01DA007339-18NIDA NIH HHS R56 DA000564NIDA NIH HHS R56DA000564-40PHS HHS R01023905-05A1
6 · The paper itself

Abstract

Protein kinase C (PKC) activation plays an important role in morphine-induced μ-opioid receptor (OPRM1) desensitization and tolerance development. It was recently shown that receptor phosphorylation by G protein-coupled receptor kinase regulates agonist-dependent selective signaling and that inefficient phosphorylation of OPRM1 leads to PKCε activation and subsequent responses. Here, we demonstrate that such receptor phosphorylation and PKCε activation can be modulated by FK506-binding protein 12 (FKBP12). Using a yeast two-hybrid screen, FKBP12 was identified as specifically interacting with OPRM1 at the Pro(353) residue. In human embryonic kidney 293 cells expressing OPRM1, the association of FKBP12 with OPRM1 decreased the agonist-induced receptor phosphorylation at Ser(375). The morphine-induced PKCε activation and the recruitment of PKCε to the OPRM1 signaling complex were attenuated both by FKBP12 short interfering RNA (siRNA) treatment and in cells expressing OPRM1 with a P353A mutation (OPRM1P353A), which leads to diminished activation of PKC-dependent extracellular signal-regulated kinases. Meanwhile, the overexpression of FKBP12 enabled etorphine to activate PKCε. Further analysis of the receptor complex demonstrated that morphine treatment enhanced the association of FKBP12 and calcineurin with the receptor. The blockade of the FKBP12 association with the receptor by the siRNA-mediated knockdown of endogenous FKBP12 or the mutation of Pro(353) to Ala resulted in a reduction in PKCε and calcineurin recruitment to the receptor signaling complex. The receptor-associated calcineurin modulates OPRM1 phosphorylation, as demonstrated by the ability of the calcineurin autoinhibitory peptide to increase the receptor phosphorylation. Thus, the association of FKBP12 with OPRM1 attenuates the phosphorylation of the receptor and triggers the recruitment and activation of PKCε.

Indexed as

AnimalsCalcineurinEnzyme ActivationHEK293 CellsHumansMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Models, MolecularMorphineMutationPhosphorylationProtein Kinase C-epsilonProtein TransportRatsReceptors, Opioid, muSignal TransductionCalcineurinMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3MorphineOprm1 protein, ratProtein Kinase C-epsilonReceptors, Opioid, muTacrolimus Binding Protein 1A

Identifiers

PMID24113748
PMCPMC3868904
OpenAlexW2105148401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.